Marinus Pharma (MRNS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov13

Marinus Pharma released FY2024 Q3 earnings on November 12 (EST), actual revenue $8.541M (forecast $9.422M), actual EPS -0.4232 (forecast -0.417)

04:00

Marinus Pharma released FY2024 9 Months Earnings on November 12, 2024 (EST), with actual revenue of 24.28M USD and EPS of -1.7334

04:00

Oct17

Marinus Pharmaceuticals Releases Key Clinical Data on Refractory Status Epilepticus RAISE Trial

11:39

Aug2

Faruqi & Faruqi, LLP is investigating potential claims against Marinus Pharmaceuticals, Inc. for violations of federal securities laws

14:41

Jul29

Marinus Pharmaceuticals, Inc. files securities fraud class action lawsuit

12:39

Jul22

Reminder of Deadline in Class Action Lawsuit Against Marinus Pharmaceuticals, Inc.

16:40

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 8.541 M, Net Income -24.23 M, EPS -0.4232

Aug13

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 8.056 M, Net Income -35.83 M, EPS -0.63

May8

Earning Release(EST)

FY2024 Q1 Earning Release (USD) Revenue 7.679 M, Net Income -38.67 M, EPS -0.6801

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More